CURRENT DRUG TARGETS, 1389-4501

Journal

  1. 2017
  2. 2013
  3. Tsiligianni, I. G., Kosmas, E., Van der Molen, T., & Tzanakis, N. (2013). Managing Comorbidity in COPD: A Difficult Task. CURRENT DRUG TARGETS, 14(2), 158-176.
  4. 2011
  5. Mahalingam, D., Oldenhuis, C. N. A. M., Szegezdi, E., Giles, F. J., de Vries, E. G. E., de Jong, S., & Nawrocki, S. T. (2011). Targeting Trail Towards the Clinic. CURRENT DRUG TARGETS, 12(14), 2079-2090.
  6. 2010
  7. 2009
  8. Dremencov, E., el Mansari, M., & Blier, P. (2009). Brain Norepinephrine System as a Target for Antidepressant and Mood Stabilizing Medications. CURRENT DRUG TARGETS, 10(11), 1061-1068.
  9. 2006
  10. 2004
  11. Schultz, MJ., & Kesecioglu, J. (2004). Is surfactant a promising additive drug in ALI/ARDS-patients? CURRENT DRUG TARGETS, 5(5), 445-448.

ID: 2003632